Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication  Panagiotis Koutakis, MS, Iraklis I. Pipinos,

Slides:



Advertisements
Similar presentations
INTRODUCTION Positive Ankle Work is Decreased in Peripheral Arterial Disease Before the Onset of Claudication Pain Before the Onset of Claudication Pain.
Advertisements

Stair Gait Lecture Notes.
Kinesiology Laboratory 8
Normal human gait: Ankle motion: Ankle is? Talus is the last bone of the vertical weight bearing system, weight is then transferred forwards and backwards.
Progression: The basic objective of the locomotor system is to move the body forward from the current site to a new location so the hands and head can.
Gait Analysis Study of human locomotion Walking and running
INTRODUCTION Gait Biomechanics Are Not Improved Following Supervised Treadmill Exercise In Patients With Peripheral Arterial Disease Bryon C. Applequist.
The Gait Cycle:.
Discussion Figure 3 shows data from the same subject’s lead leg during planned gait termination. The lead leg arrived first at the quiet stance position.
Gait.
Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
2) Knee.
Date of download: 10/17/2017 Copyright © ASME. All rights reserved.
Date of download: 11/2/2017 Copyright © ASME. All rights reserved.
Range of Motion and Walking Distances in Subjects with Peripheral Artery Disease Sarah Bakera, Iraklis Pipinosb,c, Jason Johanningb,c, and Sara Myersa,b.
Human Gait.
Normal Gait.
Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication  Saskia.
Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication  Jonathan Golledge, MChir, MA, FRCS, FRACS, Anthony.
Jason N. MacTaggart, MD, Iraklis I. Pipinos, MD, Jason M
Lindy N. M. Gommans, MD, Marc R. M. Scheltinga, MD, PhD, Marc R. H. M
Altered joint kinematics and increased electromyographic muscle activity during walking in patients with intermittent claudication  Lindy N.M. Gommans,
Impact of lower limbs' arterial calcification on the prevalence and severity of PAD in patients on hemodialysis  Takayasu Ohtake, MD, PhD, Machiko Oka,
Daniel J. Amaranto, BA, Farah Abbas, MS, Seth Krantz, MD, William H
Melissa M. Scott-Pandorf, MS, Nicholas Stergiou, PhD, Jason M
Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral.
Higher body mass index is associated with more adverse changes in calf muscle characteristics in peripheral arterial disease  Zankhana Raval, MD, Kiang.
Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease  Mary McGrae McDermott, MD,
Peripheral arterial disease affects kinematics during walking
Evaluation of hyperspectral technology for assessing the presence and severity of peripheral artery disease  Jason A. Chin, BSE, Edward C. Wang, PhD,
Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease  Bradley Sanderson, MSc, Christopher Askew, PhD,
A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences  Birgitta Sigvant,
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Development and validation of a risk calculator for prediction of mortality after infrainguinal bypass surgery  Prateek K. Gupta, MD, Bala Ramanan, MBBS,
Jason N. MacTaggart, MD, Iraklis I. Pipinos, MD, Jason M
The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease  Atul Jain, MD, Kiang Liu,
Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease  Hirotomo Uchiyama, MD, Reiji Hattori, MD,
Gait variability is altered in patients with peripheral arterial disease  Sara A. Myers, MS, Jason M. Johanning, MD, Nick Stergiou, PhD, Rolando I. Celis,
Lower extremity arterial inflow is adversely affected in patients with venous disease  David J. Paolini, MD, Anthony J. Comerota, MD, RVT, Linda S. Jones,
Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease  Louise S. Londero, MD, Jes S. Lindholt,
Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting.
The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects  Victor Aboyans,
Functional popliteal artery entrapment syndrome: A poorly understood and often missed diagnosis that is frequently mistreated  William D. Turnipseed,
Panagiotis Koutakis, BS, Jason M. Johanning, MD, Gleb R
Preoperative Ankle-Brachial Index Stratification for Patients With Peripheral Arterial Disease  Yifei Sun, MD, Ashish Singal, PhD, Rumi Faizer, MD, Alan.
A prospective comparison of bilateral photoplethysmography versus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral.
The EXercise versus Angioplasty in Claudication Trial (EXACT): Reasons for recruitment failure and the implications for research into and treatment of.
Anthony S. Leicht, PhD, Robert G
Is There a Relationship Between Fatigue Questionnaires and Gait Mechanics in Persons With Multiple Sclerosis?  Jessie M. Huisinga, PhD, Mary L. Filipi,
Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China  Yao He, MD, PhD, Yong Jiang,
Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD 
Bala Ramanan, MBBS, Prateek K
Effect of carbohydrate supplementation on walking performance in peripheral arterial disease: A preliminary physiologic study  Glenn A. Barker, PhD, Simon.
A Novel Large-Animal Model of Peripheral Arterial Disease
Quality of life of patients with Takayasu’s arteritis
The toe-brachial index in the diagnosis of peripheral arterial disease
Molly Schieber, Ryan M. Hasenkamp, Nick Stergiou, PhD, Jason M
Poor health-related quality of life in patients with peripheral arterial disease: Type D personality and severity of peripheral arterial disease as independent.
Lower extremity artery stenosis distribution in an unselected elderly population and its relation to a reduced ankle-brachial index  Johan Wikström, MD,
Upper- versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease  John M.
Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese  XiaoMin Yang, MD, Kai Sun, PhD, WeiLi.
Compensatory advantages of toe walking
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment  Ralf W. Sprengers, MD, Martin Teraa,
Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R
Emily Spangler, Robert W. Chang, Philip P. Goodney 
Saskia P. A. Nicolaï, MD, PhD, Erik J. M. Hendriks, PhD, Martin H
Current evidence and clinical implications of aspirin resistance
Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease  Eric P. Brass, MD,
Long-term results of peripheral arterial disease rehabilitation
Presentation transcript:

Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication  Panagiotis Koutakis, MS, Iraklis I. Pipinos, MD, Sara A. Myers, MS, Nicholas Stergiou, PhD, Thomas G. Lynch, MD, Jason M. Johanning, MD  Journal of Vascular Surgery  Volume 51, Issue 1, Pages 80-88 (January 2010) DOI: 10.1016/j.jvs.2009.07.117 Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 1 An illustration of the stance phase of walking with the dominant flexor and extensor muscle groups that are involved in the three phases is produced. The dominant muscle groups are identified in red if they contract concentrically and in purple if they contract eccentrically. a, Early stance phase lasts from ipsilateral heel strike to contralateral toe off thus covering the first double support phase (initial 20% of stance). The right leg is accepting the majority of body weight as it descends from previously being in single support on the left leg. In this phase, the right hip extensors concentrically contract to extend the hip, the knee extensors eccentrically contract to allow the knee to bend, and the ankle dorsiflexors eccentrically contract to maintain ankle dorsiflexion. b, Mid stance phase lasts from contralateral (here left) toe off until contralateral heel strike. During single support, the body is at its highest point over the extended ipsilateral leg. The body has maximum potential energy preparing to fall forward for the next double support. Limited muscular contractions are needed during this phase except when the knee extensors contract concentrically to extend the knee and straighten the leg. c, Late stance lasts from contralateral heel strike to ipsilateral toe off. It is the final 20% of stance and is the second double support phase. In this phase, the body is propelled forward onto the extended left leg mainly by the action of the ankle plantar flexors. Functionally, these muscles contract concentrically and accelerate the leg and the trunk forward and upward over the left leg thus providing forward progression and weight support. Journal of Vascular Surgery 2010 51, 80-88DOI: (10.1016/j.jvs.2009.07.117) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 2 The ensemble-average joint torque curves of the affected limb for the patients with peripheral arterial disease-pain free (PAD-PF) and peripheral arterial disease-with pain (PAD-P; n = 24 limbs) and the healthy controls (control, n = 20 limbs) during the stance phase for the (a) ankle and (b) knee joints. Torques are normalized to body mass in kg. Error bars represent the standard deviation of the mean values. ADT, Ankle dorsiflexion torque; APT, ankle plantar flexion torque; KET, extensor torque; KFT, flexor torque. bP <.05, Significant differences between groups (PAD-PF affected limb vs control). dP <.05, Significant differences between groups (PAD-P affected limb vs control). eP <.05, Significant differences between testing conditions (PAD-PF vs PAD-P). Journal of Vascular Surgery 2010 51, 80-88DOI: (10.1016/j.jvs.2009.07.117) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 3 The ensemble-average joint power curves of the affected limb for the patients with peripheral arterial disease-pain free (PAD-PF) and peripheral arterial disease-with pain (PAD-P; n = 24 limbs) and the healthy controls (control, n = 20 limbs) during the stance phase for the (a) ankle and (b) knee joints. Note: A1 ankle power absorption in late mid stance, A2 ankle power generation in late stance, K1 knee power absorption in early stance, K2 knee power generation in early stance, K3 knee power absorption in late stance. Error bars represent the standard deviation of the mean values. bP <.05, Significant differences between groups (PAD-PF affected limb vs control). dP <.05, Significant differences between groups (PAD-P affected limb vs control). eP <.05, Significant differences between testing conditions (PAD-PF vs PAD-P). Journal of Vascular Surgery 2010 51, 80-88DOI: (10.1016/j.jvs.2009.07.117) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 4 The ensemble-average joint power curves of the non-affected limb for the patients with peripheral arterial disease-pain free (PAD-PF) and peripheral arterial disease-with pain (PAD-P; n = 24 limbs) and the healthy controls (control, n = 20 limbs) during the stance phase for the (a) ankle and (b) knee, joints. A1, Ankle power absorption in late mid stance; A2, ankle power generation in late stance; K1, knee power absorption in early stance; K2, knee power generation in early mid stance; K3, knee power absorption in late stance. Error bars represent the standard deviation of the mean values. aP <.05, Significant differences between groups (PAD-PF, nonaffected limb vs control). cP <.05, Significant differences between groups (PAD-P, nonaffected limb vs control). eP <.05, Significant differences between testing conditions (PAD-PF vs PAD-P). Journal of Vascular Surgery 2010 51, 80-88DOI: (10.1016/j.jvs.2009.07.117) Copyright © 2010 Society for Vascular Surgery Terms and Conditions